CH420491A - Procédé de préparation d'unités d'agents de diagnostics, et unité obtenue par la mise en oeuvre de ce procédé - Google Patents
Procédé de préparation d'unités d'agents de diagnostics, et unité obtenue par la mise en oeuvre de ce procédéInfo
- Publication number
- CH420491A CH420491A CH333264A CH333264A CH420491A CH 420491 A CH420491 A CH 420491A CH 333264 A CH333264 A CH 333264A CH 333264 A CH333264 A CH 333264A CH 420491 A CH420491 A CH 420491A
- Authority
- CH
- Switzerland
- Prior art keywords
- units
- carrying
- unit obtained
- diagnostic agents
- preparation
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 11
- 239000000032 diagnostic agent Substances 0.000 title claims description 9
- 229940039227 diagnostic agent Drugs 0.000 title claims description 9
- 238000002360 preparation method Methods 0.000 title description 2
- 239000000126 substance Substances 0.000 claims description 6
- 239000002872 contrast media Substances 0.000 claims description 5
- OIRFJRBSRORBCM-UHFFFAOYSA-N Iopanoic acid Chemical compound CCC(C(O)=O)CC1=C(I)C=C(I)C(N)=C1I OIRFJRBSRORBCM-UHFFFAOYSA-N 0.000 claims description 4
- 235000013399 edible fruits Nutrition 0.000 claims description 4
- 108010010803 Gelatin Proteins 0.000 claims description 3
- 239000008273 gelatin Substances 0.000 claims description 3
- 229920000159 gelatin Polymers 0.000 claims description 3
- 235000019322 gelatine Nutrition 0.000 claims description 3
- 235000011852 gelatine desserts Nutrition 0.000 claims description 3
- 235000015110 jellies Nutrition 0.000 claims description 3
- 239000008274 jelly Substances 0.000 claims description 3
- 125000003118 aryl group Chemical group 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 claims description 2
- 235000013861 fat-free Nutrition 0.000 claims description 2
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 claims 1
- 235000013736 caramel Nutrition 0.000 claims 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 235000000346 sugar Nutrition 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 235000011034 Rubus glaucus Nutrition 0.000 description 4
- 244000235659 Rubus idaeus Species 0.000 description 4
- 235000009122 Rubus idaeus Nutrition 0.000 description 4
- 159000000000 sodium salts Chemical class 0.000 description 4
- 206010013911 Dysgeusia Diseases 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- 238000004040 coloring Methods 0.000 description 3
- 210000000232 gallbladder Anatomy 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 235000010419 agar Nutrition 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 210000004211 gastric acid Anatomy 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- -1 sucrose or glucose Chemical class 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 244000215068 Acacia senegal Species 0.000 description 1
- 240000001592 Amaranthus caudatus Species 0.000 description 1
- 235000009328 Amaranthus caudatus Nutrition 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 241000206672 Gelidium Species 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000012735 amaranth Nutrition 0.000 description 1
- 239000004178 amaranth Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 238000009606 cholecystography Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 235000021552 granulated sugar Nutrition 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 235000015149 toffees Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
- A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
- A61K49/0495—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound intended for oral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL290321A NL121095C (en, 2012) | 1963-03-18 | 1963-03-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH420491A true CH420491A (fr) | 1966-09-15 |
Family
ID=19754534
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH333264A CH420491A (fr) | 1963-03-18 | 1964-03-14 | Procédé de préparation d'unités d'agents de diagnostics, et unité obtenue par la mise en oeuvre de ce procédé |
Country Status (5)
| Country | Link |
|---|---|
| BE (1) | BE644888A (en, 2012) |
| CH (1) | CH420491A (en, 2012) |
| ES (1) | ES297621A1 (en, 2012) |
| GB (1) | GB1020943A (en, 2012) |
| NL (1) | NL121095C (en, 2012) |
-
1963
- 1963-03-18 NL NL290321A patent/NL121095C/xx active
-
1964
- 1964-03-06 ES ES297621A patent/ES297621A1/es not_active Expired
- 1964-03-09 BE BE644888D patent/BE644888A/xx unknown
- 1964-03-14 CH CH333264A patent/CH420491A/fr unknown
- 1964-03-18 GB GB1147164A patent/GB1020943A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| ES297621A1 (es) | 1964-08-16 |
| BE644888A (en, 2012) | 1964-07-01 |
| GB1020943A (en) | 1966-02-23 |
| NL121095C (en, 2012) | 1966-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0287488B1 (fr) | Médicament, produit diététique et produit d'hygiène sous la forme d'une composition pulvérulente obtenue par adsorption de principes actifs sur un sucre à dissolution rapide et procédé d'obtention de ladite composition | |
| JPS5962519A (ja) | ナイスタチン組成物 | |
| BE1015217A5 (en, 2012) | ||
| FR2593065A1 (fr) | Couples effervescents, compositions effervescentes d'antagonistes h2 de l'histamine les contenant et leur preparation. | |
| US20200390709A1 (en) | Procedure for preparing enteric-coated pellets containing a proton pump inhibitor and multi-particle pharmaceutical compositions containing them | |
| FR2577136A1 (fr) | Preparations pharmaceutiques a activite analgesique comportant des sels de diclofenac et de codeine, ainsi que leur fabrication et leur utilisation | |
| FR2640505A1 (fr) | Preparation pour l'apport de fer, preparation pour l'apport de vitamines et procede pour stabiliser une preparation effervescente | |
| WO2004032942A1 (fr) | Formulation orale seche a visee phlebotonique et vasculoprotectrice pour le traitement de l'insuffisance veineuse, de la fragilite capillaire et de la crise hemorroidaire, sous forme pharmaceutique de comprime a croquer contenant de la diosmine | |
| FR2616329A1 (fr) | Nouvelles compositions laxatives et leur procede d'obtention | |
| DE4122167A1 (de) | Tablette und granulat enthaltend als wirkstoff mesna | |
| CH420491A (fr) | Procédé de préparation d'unités d'agents de diagnostics, et unité obtenue par la mise en oeuvre de ce procédé | |
| EP0806949B1 (fr) | Nouvelle composition pharmaceutique contenant la trimebutine et son procede de preparation | |
| CA1163923A (fr) | Procede d'enrobage d'au moins un principe actif medicamenteux | |
| BE1000189A3 (fr) | Preparation pharmaceutique a usage veterinaire. | |
| US3419657A (en) | Iodopanoic acid in a hydrogel | |
| EP0116182B2 (fr) | Procédé de préparation d'acide p-butoxyphénylacéthydroxamique à l'état finement divisé | |
| DE69729729T2 (de) | Arzneimittel zur anwendung im mund | |
| FR2493146A1 (fr) | Melange de cromoglycate de sodium avec un excipient hydrosoluble et procede pour sa preparation pour traiter les affections du tractus gastro-intestinal | |
| FR2823M (en, 2012) | ||
| BE1007926A3 (fr) | Composition pharmaceutique contenant de la n-acetyl-cysteine. | |
| CA2022447A1 (fr) | Forme galenique orale ameliorant la biodisponibilite | |
| FR3120788A1 (fr) | Composition nutraceutique pour le traitement et la prevention des troubles oculaires | |
| BE819863A (fr) | Compositions d'antibiotiques du type virginiamycine pour administration orale. | |
| FR2680972A1 (fr) | Procede de preparation de substances pharmaceutiquement actives a partir de la plante mimosa pudica linn, substances pharmaceutiquement actives ainsi obtenues et compositions pharmaceutiques les contenant. | |
| FR2724112A1 (fr) | Composition contenant l'association du facteur intrinseque et de l'insuline |